Follow-up results after interventional treatment of infarct-related saphenous vein graft occlusion

Coronary Artery Disease

Volumn 21, Issue 2, 2010, Pages 61-64

  Hoffmann, Rainer ^a   Nitendo, Giadino ^a   Deserno, Verena ^a   Adamu, Umar ^a   Almalla, Mohammed ^a   Blindt, Rüdiger ^a   Vogt, Felix ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Myocardial infarction; Restenosis; Saphenous vein grafts; Stent

Indexed keywords

TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GRAFT OCCLUSION; HEART INFARCTION; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; SAPHENOUS VEIN GRAFT;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY CIRCULATION; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSTHESIS DESIGN; RECURRENCE; SAPHENOUS VEIN; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 77249125957     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328332ee4b     Document Type: Article

References (17)

1. FitzGibbon GM, Leach AJ, Kafka HP, Keon WJ. Coronary bypass graft fate: long term angiographic study. J Am Coll Cardiol 1991; 17:1075-1080.
2. Weintraub WS, Jones EL, Caver JM, Guyton RA. Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts. Am J Cardiol 1994; 73:103-112.
3. Frimerman A, Rechavia E, Eigler N, Payton MR, Makkar R, Litvack F. Long-term follow-up of a high risk cohort after stent implantation in saphenous vein grafts. J Am Coll Cardiol 1997; 30:1277-1283.
4. Savage MP, Douglas JS, Fischman DL, Pepine CJ, King SB III, Werner JA, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997; 337:740-747.
5. Keeley EC, Velez CA, O ́ Neill WW, Safian RD. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol 2001; 38:659-665.
6. Vignali L, Saia F, Manari A, Santarelli A, Rubboli A, Varani E, et al. Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the Registro Regionale AngiopLastiche Emilia-Romagna Registry). Am J Cardiol 2008; 101:947-952.
7. Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, van den Branden F, Van Langenhove G. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts. J Am Coll Cardiol 2007; 80:261-267.
8. De Jaegere PP, van Domburg RT, Feyter PJ, Ruygrok PN, van der GiessenWJ, van den Brand MJ, Serruys PW. Long-term clinical outcome after stent implantation in saphenous vein grafts. J Am Coll Cardiol 1996; 28:89-96.
9. Serruys PW, Daemen J. Are drug-eluting stents associated with a higher rate of late stent thrombosis than bare metal stents? Circulation 2007; 115:1433-1439.
10. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA Guidelines for the management of patients with ST-elevation myocardial infarction - executive summary. Circulation 2004; 110:588-636.
11. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, et al. Guidelines for the diagnosis and treatment of non-ST-elevation acute coronary syndromes. Eur Heart J 2007; 28:1598-1660.
12. Ellis SG, Brener SJ, DeLuca S, Tuzcu EM, Raymond RE, Whitlow PL, Topol EJ. Late myocardial ischemic events after saphenous vein graft intervention - importance of initially 'non-significant' vein graft lesions. Am J Cardiol 1997; 79:1460-1464.
13. Hoffmann R, Pohl T, Kö ster R, Blindt R, Boeckstegers P, Heitzer T. Implantation of paclitaxel-eluting stents in saphenous vein grafts. Clinical and angiographic follow-up results from a multicenter study. Heart 2007; 93:331-334. (Pubitemid 46579523)
14. Mauri L, Silbaugh TS, Garg P, Wolf RE, Zelevinskv K, Lovett A, et al. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med 2008; 359:1330-1342.
15. Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, et al. Meta-analysis of randomized trials on drug-eluting stents versus bare-metal stents in patients with acute myocardial infarction. Eur Heart J 2007; 28:2706-2713. (Pubitemid 350139205)
16. Kelbaek H, Thuesen L, Helgvist S, Clemmensen P, Klovgaard L, Kaltoft A, et al. Drug-eluting versus bare metal stents in patients with ST-segmentelevation myocardial infarction: eight-month follow-up in the Drug Eluting and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial. Circulation 2008; 118:1155-1162.
17. Van der Hoeven BL, Liem SS, Jukema JW, Suraphakdee N, Putter H, Dijkstra J, et al. Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION Intervention Study. J Am Coll Cardiol 2008; 51:618-626.